Annual Interest Expense
$16.74 M
+$1.36 M+8.87%
31 December 2023
Summary:
BioMarin Pharmaceutical annual interest expense is currently $16.74 million, with the most recent change of +$1.36 million (+8.87%) on 31 December 2023. During the last 3 years, it has fallen by -$10.74 million (-39.08%). BMRN annual interest expense is now -61.66% below its all-time high of $43.66 million, reached on 31 December 2018.BMRN Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$2.97 M
-$606.00 K-16.96%
30 September 2024
Summary:
BioMarin Pharmaceutical quarterly interest expense is currently $2.97 million, with the most recent change of -$606.00 thousand (-16.96%) on 30 September 2024. Over the past year, it has dropped by -$811.00 thousand (-21.46%). BMRN quarterly interest expense is now -73.54% below its all-time high of $11.22 million, reached on 30 June 2018.BMRN Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$15.59 M
-$811.00 K-4.94%
30 September 2024
Summary:
BioMarin Pharmaceutical TTM interest expense is currently $15.59 million, with the most recent change of -$811.00 thousand (-4.94%) on 30 September 2024. Over the past year, it has increased by +$1.32 million (+9.27%). BMRN TTM interest expense is now -64.36% below its all-time high of $43.75 million, reached on 30 September 2018.BMRN TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMRN Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.9% | -21.5% | +9.3% |
| 3 y3 years | -39.1% | -23.3% | +8.2% |
| 5 y5 years | -61.7% | +1.1% | -41.8% |
BMRN Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -39.1% | +13.5% | -46.1% | at low | -6.9% | +9.3% |
| 5 y | 5 years | -61.7% | +13.5% | -69.1% | +1.6% | -46.1% | +9.3% |
| alltime | all time | -61.7% | +150.7% | -73.5% | +541.0% | -64.4% | +349.0% |
BioMarin Pharmaceutical Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.97 M(-17.0%) | $15.59 M(-4.9%) |
| June 2024 | - | $3.57 M(+0.8%) | $16.40 M(-1.1%) |
| Mar 2024 | - | $3.55 M(-35.6%) | $16.59 M(-0.9%) |
| Dec 2023 | $16.74 M(+8.9%) | $5.50 M(+45.6%) | $16.74 M(+17.3%) |
| Sept 2023 | - | $3.78 M(+0.6%) | $14.27 M(-5.9%) |
| June 2023 | - | $3.75 M(+1.4%) | $15.17 M(-0.7%) |
| Mar 2023 | - | $3.70 M(+22.1%) | $15.27 M(-0.7%) |
| Dec 2022 | $15.38 M(+4.3%) | $3.03 M(-35.2%) | $15.38 M(-1.4%) |
| Sept 2022 | - | $4.68 M(+21.2%) | $15.60 M(+5.5%) |
| June 2022 | - | $3.86 M(+1.4%) | $14.79 M(+0.3%) |
| Mar 2022 | - | $3.81 M(+17.0%) | $14.75 M(+0.0%) |
| Dec 2021 | $14.74 M(-46.3%) | $3.25 M(-15.9%) | $14.74 M(+2.3%) |
| Sept 2021 | - | $3.87 M(+1.4%) | $14.41 M(-28.4%) |
| June 2021 | - | $3.82 M(+0.3%) | $20.14 M(-15.6%) |
| Mar 2021 | - | $3.80 M(+30.3%) | $23.85 M(-11.5%) |
| Dec 2020 | $27.48 M(+28.2%) | $2.92 M(-69.6%) | $26.96 M(-6.8%) |
| Sept 2020 | - | $9.60 M(+27.5%) | $28.94 M(+29.9%) |
| June 2020 | - | $7.53 M(+8.8%) | $22.28 M(+5.5%) |
| Mar 2020 | - | $6.92 M(+41.2%) | $21.11 M(+0.9%) |
| Dec 2019 | $21.43 M(-50.9%) | $4.90 M(+66.8%) | $20.92 M(-21.9%) |
| Sept 2019 | - | $2.94 M(-53.8%) | $26.79 M(-23.4%) |
| June 2019 | - | $6.36 M(-5.5%) | $34.97 M(-12.2%) |
| Mar 2019 | - | $6.73 M(-37.5%) | $39.83 M(-8.8%) |
| Dec 2018 | $43.66 M(+12.0%) | $10.76 M(-3.2%) | $43.66 M(-0.2%) |
| Sept 2018 | - | $11.12 M(-0.9%) | $43.75 M(+3.2%) |
| June 2018 | - | $11.22 M(+6.3%) | $42.37 M(+5.1%) |
| Mar 2018 | - | $10.56 M(-2.7%) | $40.31 M(+3.4%) |
| Dec 2017 | $38.98 M(+7.9%) | $10.85 M(+11.3%) | $38.98 M(+5.4%) |
| Sept 2017 | - | $9.75 M(+6.5%) | $36.97 M(+1.6%) |
| June 2017 | - | $9.15 M(-0.9%) | $36.38 M(+0.1%) |
| Mar 2017 | - | $9.23 M(+4.4%) | $36.35 M(+0.6%) |
| Dec 2016 | $36.13 M | $8.84 M(-3.4%) | $36.13 M(+0.9%) |
| Sept 2016 | - | $9.15 M(+0.4%) | $35.80 M(+1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | $9.12 M(+1.1%) | $35.27 M(-0.2%) |
| Mar 2016 | - | $9.02 M(+6.0%) | $35.33 M(+1.1%) |
| Dec 2015 | $34.95 M(+4.9%) | $8.51 M(-1.3%) | $34.95 M(+0.4%) |
| Sept 2015 | - | $8.62 M(-6.1%) | $34.81 M(+1.0%) |
| June 2015 | - | $9.18 M(+6.3%) | $34.48 M(+2.4%) |
| Mar 2015 | - | $8.64 M(+3.2%) | $33.68 M(+1.1%) |
| Dec 2014 | $33.31 M(+255.5%) | $8.37 M(+1.0%) | $33.31 M(+4.7%) |
| Sept 2014 | - | $8.29 M(-1.2%) | $31.81 M(+32.6%) |
| June 2014 | - | $8.39 M(+1.5%) | $23.98 M(+48.7%) |
| Mar 2014 | - | $8.26 M(+20.3%) | $16.13 M(+72.1%) |
| Dec 2013 | $9.37 M(+40.3%) | $6.87 M(+1383.6%) | $9.37 M(+169.9%) |
| Sept 2013 | - | $463.00 K(-12.8%) | $3.47 M(-28.3%) |
| June 2013 | - | $531.00 K(-64.8%) | $4.85 M(-22.3%) |
| Mar 2013 | - | $1.51 M(+55.6%) | $6.24 M(-6.6%) |
| Dec 2012 | $6.68 M(-20.6%) | $970.00 K(-47.2%) | $6.68 M(-12.0%) |
| Sept 2012 | - | $1.84 M(-4.6%) | $7.59 M(-4.2%) |
| June 2012 | - | $1.93 M(-1.1%) | $7.92 M(-3.4%) |
| Mar 2012 | - | $1.95 M(+3.7%) | $8.19 M(-2.6%) |
| Dec 2011 | $8.41 M(-22.3%) | $1.88 M(-13.4%) | $8.41 M(-9.4%) |
| Sept 2011 | - | $2.17 M(-1.5%) | $9.28 M(-8.3%) |
| June 2011 | - | $2.20 M(+1.8%) | $10.12 M(-4.1%) |
| Mar 2011 | - | $2.16 M(-21.2%) | $10.55 M(-2.5%) |
| Dec 2010 | $10.82 M(-23.2%) | $2.75 M(-8.7%) | $10.82 M(+0.3%) |
| Sept 2010 | - | $3.01 M(+14.2%) | $10.79 M(+1.2%) |
| June 2010 | - | $2.63 M(+8.5%) | $10.66 M(-14.2%) |
| Mar 2010 | - | $2.43 M(-10.5%) | $12.43 M(-11.8%) |
| Dec 2009 | $14.09 M(-14.1%) | $2.71 M(-5.7%) | $14.09 M(-8.9%) |
| Sept 2009 | - | $2.88 M(-34.6%) | $15.47 M(-7.3%) |
| June 2009 | - | $4.40 M(+7.8%) | $16.69 M(+2.0%) |
| Mar 2009 | - | $4.09 M(-0.2%) | $16.37 M(+33.3%) |
| Dec 2008 | $16.39 M | $4.10 M(-0.2%) | $12.28 M(+50.0%) |
| Sept 2008 | - | $4.11 M(+0.6%) | $8.19 M(+100.6%) |
| June 2008 | - | $4.08 M | $4.08 M |
FAQ
- What is BioMarin Pharmaceutical annual interest expense?
- What is the all time high annual interest expense for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual interest expense year-on-year change?
- What is BioMarin Pharmaceutical quarterly interest expense?
- What is the all time high quarterly interest expense for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly interest expense year-on-year change?
- What is BioMarin Pharmaceutical TTM interest expense?
- What is the all time high TTM interest expense for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical TTM interest expense year-on-year change?
What is BioMarin Pharmaceutical annual interest expense?
The current annual interest expense of BMRN is $16.74 M
What is the all time high annual interest expense for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual interest expense is $43.66 M
What is BioMarin Pharmaceutical annual interest expense year-on-year change?
Over the past year, BMRN annual interest expense has changed by +$1.36 M (+8.87%)
What is BioMarin Pharmaceutical quarterly interest expense?
The current quarterly interest expense of BMRN is $2.97 M
What is the all time high quarterly interest expense for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly interest expense is $11.22 M
What is BioMarin Pharmaceutical quarterly interest expense year-on-year change?
Over the past year, BMRN quarterly interest expense has changed by -$811.00 K (-21.46%)
What is BioMarin Pharmaceutical TTM interest expense?
The current TTM interest expense of BMRN is $15.59 M
What is the all time high TTM interest expense for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high TTM interest expense is $43.75 M
What is BioMarin Pharmaceutical TTM interest expense year-on-year change?
Over the past year, BMRN TTM interest expense has changed by +$1.32 M (+9.27%)